Browsing: vaping

Three large Chinese vape companies are researching nicotine-like chemicals as potential nicotine substitutes in vapes. Regulators have warned that some chemicals may be more potent and addictive than nicotine itself, and more studies are needed to understand health impacts.

The vape and e-cigarette industry’s expansion into the Philippines, with aspirations to establish the country as a manufacturing hub for these products, has sparked concern among medical professionals. This trajectory, they warn, carries the ominous potential of fostering an epidemic of EVALI, or e-cigarette or vape-associated lung injury, particularly among the nation’s youth.

Further, research also highlighted concerning trends, including the emergence of respiratory and cardiovascular issues from e-cigarette use. A recently published cohort study from Hebei province, China, provides pivotal evidence linking chronic obstructive pulmonary disease (COPD) and vaping. The study tracked over 10,000 healthy participants without prior respiratory conditions from 2015 to 2020. At the end of the study, the researchers found a 28% increase in the risk of respiratory symptoms. It also found a 8% increase in the risk of COPD in e-cigarette users. Additionally, dual users who use both e-cigarettes and conventional cigarettes had a 41% and 18% increased risk in respiratory symptoms and COPD risks. These findings contribute to the growing body of evidence cautioning against the use of e-cigarettes and highlight the need for healthcare professionals and policymakers to reassess the role of vaping in smoking cessation strategies.

Log In or Register as a healthcare professional to read the full article.